{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:54:34Z","timestamp":1788872074721,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["31003A-130710"],"award-info":[{"award-number":["31003A-130710"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["31003A-134926"],"award-info":[{"award-number":["31003A-134926"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.bbrc.2011.08.001","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T19:17:37Z","timestamp":1312744657000},"page":"572-577","source":"Crossref","is-referenced-by-count":35,"title":["Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency"],"prefix":"10.1016","volume":"412","author":[{"given":"Christa E.","family":"Fl\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinane","family":"Samara-Boustani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Leger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.08.001_b0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley\u2013Bixler syndrome","volume":"36","author":"Fl\u00fcck","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2011.08.001_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000321221","article-title":"Clinical and biochemical consequences of p450 oxidoreductase deficiency","volume":"20","author":"Fl\u00fcck","year":"2011","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.bbrc.2011.08.001_b0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/me.2010-0236","article-title":"Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms","volume":"25","author":"Tee","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2010.10.022","article-title":"Consequences of POR mutations and polymorphisms","volume":"336","author":"Miller","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0021-9258(19)51185-1","article-title":"Triphosphate nucleotide\u2013cytochrome c reductase in liver","volume":"183","author":"Horecker","year":"1950","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0030","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/S0021-9258(18)83427-5","article-title":"Resolution of the cytochrome P-450-containing w-hydroxylation system of liver microsomes into three components","volume":"244","author":"Lu","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0035","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/S0021-9258(19)45183-1","article-title":"Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system","volume":"247","author":"Schacter","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0040","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1016\/S0021-9258(19)57476-2","article-title":"Preparation and characterization of FAD-dependent NADPH\u2013cytochrome P-450 reductase","volume":"261","author":"Kurzban","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0045","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM198511073131903","article-title":"Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases A new variant of congenital adrenal hyperplasia","volume":"313","author":"Peterson","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2011.08.001_b0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2011.08.001_b0055","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM198605153142015","article-title":"Congenital adrenal hyperplasia","volume":"314","author":"Miller","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2011.08.001_b0060","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1074\/jbc.M111408200","article-title":"Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH\u2013cytochrome P450 oxidoreductase","volume":"277","author":"Shen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0065","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2011.08.001_b0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.30169","article-title":"Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley\u2013Bixler syndrome","volume":"128A","author":"Adachi","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2011.08.001_b0075","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley\u2013Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2011.08.001_b0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.mce.2010.02.024","article-title":"Restoration of mutant cytochrome P450 reductase activity by external flavin","volume":"321","author":"Nicolo","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2009.09.001","article-title":"Modeling of human P450 oxidoreductase structure by in silico mutagenesis and Md simulation","volume":"313","author":"Fl\u00fcck","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1472-8206.2007.00520.x","article-title":"Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase","volume":"21","author":"Fl\u00fcck","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000134826","article-title":"P450 oxidoreductase deficiency \u2013 a new form of congenital adrenal hyperplasia","volume":"13","author":"Fl\u00fcck","year":"2008","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.bbrc.2011.08.001_b0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abb.2008.04.014","article-title":"Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley\u2013Bixler syndrome variants of cytochrome P450 oxidoreductase","volume":"475","author":"Kranendonk","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2011.08.001_b0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FPC.0b013e32830054ac","article-title":"Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19","volume":"18","author":"Agrawal","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bbrc.2011.08.001_b0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/pgs.09.7","article-title":"Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation","volume":"10","author":"Gomes","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbrc.2011.08.001_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FPC.0b013e3282f2f121","article-title":"Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism","volume":"18","author":"Hart","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bbrc.2011.08.001_b0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2010.08.072","article-title":"Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase","volume":"400","author":"Pandey","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.08.001_b0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2010.09.035","article-title":"Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism","volume":"401","author":"Fl\u00fcck","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.08.001_b0130","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/me.2007-0245","article-title":"Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase","volume":"21","author":"Pandey","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/eje.1.02172","article-title":"Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein","volume":"155","author":"Janner","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0140","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1074\/jbc.M807868200","article-title":"Structure and function of an NADPH\u2013cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450","volume":"284","author":"Hamdane","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"52\u20136","key":"10.1016\/j.bbrc.2011.08.001_b0145","first-page":"29","article-title":"WHAT IF: a molecular modeling and drug design program","volume":"8","author":"Vriend","year":"1990","journal-title":"J. Mol. Graphics"},{"key":"10.1016\/j.bbrc.2011.08.001_b0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2011.08.001_b0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/prot.20251","article-title":"Making optimal use of empirical energy functions: force-field parameterization in crystal space","volume":"57","author":"Krieger","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.bbrc.2011.08.001_b0160","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0076-6879(96)72008-6","article-title":"Yeast expression of animal and plant P450s in optimized redox environments","volume":"272","author":"Pompon","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrc.2011.08.001_b0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/abio.1998.2997","article-title":"A colorimetric assay for heme in biological samples using 96-well plates","volume":"268","author":"Pandey","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/bbrc.2001.5338","article-title":"Activities and kinetic mechanisms of native and soluble NADPH\u2013cytochrome P450 reductase","volume":"286","author":"Lamb","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.08.001_b0180","doi-asserted-by":"crossref","first-page":"15992","DOI":"10.1016\/S0021-9258(18)98506-6","article-title":"Missense mutation serine106 proline causes 17\u03b1-hydroxylase deficiency","volume":"266","author":"Lin","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.08.001_b0185","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","article-title":"Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone","volume":"91","author":"Homma","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2011.08.001_b0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajhg.2011.06.009","article-title":"Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation","volume":"89","author":"Fl\u00fcck","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2011.08.001_b0195","series-title":"Functional Endocrinologic Diagnostics in Children and Adolescents","first-page":"248","article-title":"Adrenal function tests","author":"Forest","year":"1993"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1101374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1101374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T17:01:33Z","timestamp":1638205293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1101374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0006291X1101374X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.08.001","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}